| 000 | 01620 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513120447.0 | ||
| 264 | 0 | _c20061019 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a1081-4442 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlexander, H R | |
| 245 | 0 | 0 |
_aThymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma. _h[electronic resource] |
| 260 |
_bThe cancer journal from Scientific American _c |
||
| 300 |
_a49-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThymidylate Synthase _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGrem, J L | |
| 700 | 1 | _aHamilton, J M | |
| 700 | 1 | _aPass, H I | |
| 700 | 1 | _aHong, M | |
| 700 | 1 | _aFraker, D L | |
| 700 | 1 | _aSteinberg, S M | |
| 700 | 1 | _aMcAtee, N | |
| 700 | 1 | _aAllegra, B C | |
| 700 | 1 | _aJohnston, P G | |
| 773 | 0 |
_tThe cancer journal from Scientific American _gvol. 1 _gno. 1 _gp. 49-54 |
|
| 999 |
_c9147595 _d9147595 |
||